Performance & Formulation Insights
How It Works: Retinal (retinaldehyde) is a Vitamin A conversion intermediate, requiring one fewer step to reach retinoic acid than Retinol. RETINAL-S applies the same 3-step encapsulation platform (LDH primary liposome → MLV secondary liposome → combined final encapsulation) to protect this reactive intermediate from heat and light while enabling controlled, efficient delivery. Comparative studies showed ~11× faster conversion toward retinoic acid, translating into clinically measured 18-week wrinkle improvement and +9.4% dermal thickness increase.
Formulation Guidelines
Dose based on the 1.0% Retinal concentration of the complex to reach your target finished-product Retinal percentage. Incorporate into the water phase; maintain standard Vitamin A handling precautions (protect from light/heat, opaque or airless packaging) despite encapsulation.
Key Formulation Benefits:
- Faster Conversion: ~11× faster conversion toward retinoic acid in comparative studies.
- Clinically Demonstrated Efficacy: 18-week wrinkle improvement and +9.4% dermal thickness improvement.
- Enhanced Stability: Encapsulation protects against heat and light degradation.
- Controlled, Efficient Delivery: Skin-mimetic MLV structures support efficient skin delivery.